{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T11:39:50Z","timestamp":1761997190041,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T00:00:00Z","timestamp":1529020800000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["09SDG2250712"],"award-info":[{"award-number":["09SDG2250712"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1352535"],"award-info":[{"award-number":["1352535"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.xphs.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T04:32:58Z","timestamp":1492489978000},"page":"1764-1771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Excipients for Stabilizing Fiberless Adenovirus as Biopharmaceuticals"],"prefix":"10.1016","volume":"106","author":[{"given":"Grit","family":"Kupgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyamal P.","family":"Choudhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas H.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adane","family":"Nigatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravanthi","family":"Vupputuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L.","family":"Picking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Picking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JVI.73.2.907-919.1999","article-title":"Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber","volume":"73","author":"Legrand","year":"1999","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/JVI.73.2.1601-1608.1999","article-title":"A\u00a0helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles","volume":"73","author":"von Seggern","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.xphs.2017.04.013_bib3","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1099\/0022-1317-81-11-2573","article-title":"Update an adenovirus and its vectors","volume":"81","author":"Russell","year":"2000","journal-title":"J\u00a0Gen Virol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.013_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.013_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tibtech.2009.01.003","article-title":"Designer adenoviruses for nanomedicine and nanodiagnostics","volume":"27","author":"Singh","year":"2009","journal-title":"Trends Biotechnol"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.013_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12033-014-9777-6","article-title":"The effect of fiber truncations on the stability of adenovirus type 5","volume":"56","author":"Kupgan","year":"2014","journal-title":"Mol Biotechnol"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jconrel.2007.12.016","article-title":"Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors","volume":"127","author":"Kurachi","year":"2008","journal-title":"J\u00a0Control Release"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.013_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in\u00a0vitro and in\u00a0vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.xphs.2017.04.013_bib9","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A\u00a0simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.xphs.2017.04.013_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0076-6879(06)21015-2","article-title":"Recombineering: in\u00a0vivo genetic engineering in E. coli, S. enterica, and beyond","volume":"421","author":"Sawitzke","year":"2007","journal-title":"Methods Enzymol"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.013_bib11","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/gni035","article-title":"Simple and highly efficient BAC recombineering using gaIK selection","volume":"33","author":"Warming","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nprot.2008.227","article-title":"Recombineering: a homologous recombination-based method of genetic engineering","volume":"4","author":"Sharan","year":"2009","journal-title":"Nat Protoc"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/viro.2002.1406","article-title":"Evaluation of accuracy and precision of adenovirus absorptivity at 260 nm under conditions of complete DNA disruption","volume":"295","author":"Sweeney","year":"2002","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.xphs.2017.04.013_bib14","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/jps.10439","article-title":"Derivative absorbance spectroscopy and protein phase diagrams as tools for comprehensive protein characterization: a bGCSF case study","volume":"92","author":"Kueltzo","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.013_bib15","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1002\/jps.22618","article-title":"Multidimensional methods for the formulation of biopharmaceuticals and vaccines","volume":"100","author":"Maddux","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"17","key":"10.1016\/j.xphs.2017.04.013_bib16","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur J Biochem"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.013_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/jps.10340","article-title":"Structural stability of adenovirus type 5","volume":"92","author":"Rexroad","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in\u00a0vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum Gene Ther"},{"issue":"7","key":"10.1016\/j.xphs.2017.04.013_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/jps.20617","article-title":"Thermal stability of adenovirus type 2 as a function of pH","volume":"95","author":"Rexroad","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4161\/hv.6.2.10254","article-title":"Using spectroscopic and microscopic methods to probe the structural stability of human adenovirus type 4","volume":"6","author":"He","year":"2010","journal-title":"Hum Vaccin"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.013_bib21","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/jps.21931","article-title":"Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin","volume":"99","author":"Serno","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.013_bib22","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/jps.23622","article-title":"The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study","volume":"102","author":"Liu","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jps.23801","article-title":"Preformulation study of highly purified inactivated polio vaccine, serotype 3","volume":"103","author":"Qi","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/toxsci\/55.2.303","article-title":"Choline supplementation inhibits diethanolamine-induced morphological transformation in Syrian hamster embryo cells: evidence for a carcinogenic mechanism","volume":"55","author":"Lehman-McKeeman","year":"2000","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1096\/fasebj.13.1.135","article-title":"Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase","volume":"13","author":"Yen","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.xphs.2017.04.013_bib26","series-title":"Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines","first-page":"119","article-title":"High throughput screening for stabilizers of vaccine antigens","author":"Middaugh","year":"2013"},{"issue":"8","key":"10.1016\/j.xphs.2017.04.013_bib27","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/jps.23643","article-title":"A\u00a0systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccine","volume":"102","author":"Choudhari","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2017.04.013_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/jps.22330","article-title":"Identifying stabilizers of plasmid DNA for pharmaceutical use","volume":"100","author":"Zeng","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2017.04.013_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jps.20496","article-title":"Effect of pH and ionic strength on the physical stability of adenovirus type 5","volume":"95","author":"Rexroad","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.013_bib30","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1128\/JVI.02321-10","article-title":"Functional genetic and biophysical analyses of membrane disruption by human adenovirus","volume":"85","author":"Moyer","year":"2011","journal-title":"J\u00a0Virol"},{"issue":"13","key":"10.1016\/j.xphs.2017.04.013_bib31","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","article-title":"Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development","volume":"63","author":"Kamerzell","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.013_bib32","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/jps.20157","article-title":"Development of stable liquid formulations for adenovirus-based vaccines","volume":"93","author":"Evans","year":"2004","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/mthe.2001.0411","article-title":"Development of novel formulations that enhance adenoviral-mediated gene expression in the lung in\u00a0vitro and in\u00a0vivo","volume":"4","author":"Croyle","year":"2001","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.xphs.2017.04.013_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00726-007-0506-3","article-title":"Biotechnology applications of amino acids in protein purification and formulations","volume":"33","author":"Arakawa","year":"2007","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0003-9861(83)90201-1","article-title":"Preferential interactions of proteins with solvent components in aqueous amino acid solutions","volume":"224","author":"Arakawa","year":"1983","journal-title":"Arch Biochem Biophys"},{"issue":"10","key":"10.1016\/j.xphs.2017.04.013_bib36","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1023\/A:1012209007411","article-title":"Phase transitions of glycine in frozen aqueous solutions and during freeze-drying","volume":"18","author":"Pyne","year":"2001","journal-title":"Pharm Res"},{"issue":"1-2","key":"10.1016\/j.xphs.2017.04.013_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2009.09.007","article-title":"Role of naturally occurring osmolytes in protein folding and stability","volume":"491","author":"Kumar","year":"2009","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.013_bib38","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jps.10154","article-title":"Excipient-drug interactions in parenteral formulations","volume":"91","author":"Akers","year":"2002","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2017.04.013_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4615-0557-0_1","article-title":"Practical approaches to protein formulation development","volume":"13","author":"Chang","year":"2002","journal-title":"Pharm Biotechnol"},{"issue":"11","key":"10.1016\/j.xphs.2017.04.013_bib40","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/jps.21378","article-title":"High-field solution NMR spectroscopy as a tool for assessing protein interactions with small molecule ligands","volume":"97","author":"Skinner","year":"2008","journal-title":"J\u00a0Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2017.04.013_bib41","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/jps.22055","article-title":"Probing residue-specific interactions in the stabilization of proteins using high-resolution NMR: a study of disulfide bond compensation","volume":"99","author":"Skinner","year":"2010","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2017.04.013_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1110\/ps.062393707","article-title":"The effects of cosolutes on protein dynamics: the reversal of denaturant-induced protein fluctuations by trimethylamine N-oxide","volume":"16","author":"Doan-Nguyen","year":"2007","journal-title":"Protein Sci"},{"issue":"34","key":"10.1016\/j.xphs.2017.04.013_bib43","doi-asserted-by":"crossref","first-page":"9762","DOI":"10.1021\/bi700645k","article-title":"Two-dimensional correlation spectroscopy reveals coupled immunoglobulin regions of differential flexibility that influence stability","volume":"46","author":"Kamerzell","year":"2007","journal-title":"Biochemistry"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917302459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:22:22Z","timestamp":1758360142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917302459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0022354917302459"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.013","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Excipients for Stabilizing Fiberless Adenovirus as Biopharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}